Neuroendocrine Responses to High-Intensity Reactive Exercises: Effects on Catecholamine and Hormonal Profiles in Elite U-19 Volleyball Players
Acute Catecholamine and Glucocorticoid Responses to Reactive Speed, Agility, and Quickness Exercise in Elite U-19 Volleyball Players: A Randomized Controlled Study
The goal of this explored study intends to investigate how different types of speed, agility, and quickness (SAQ) exercises effect the body's immediate hormonal and physiological reactions in young male volleyball players. Physical exercise can alter the release of hormones and other substances involved in the body's response to physical effort and stress. However, it is still ambiguous if activities that necessitate swift reflexes to unforeseen visual stimuli provide distinct outcomes in contrast to conventional exercises that entail premeditated movements. The study will include 36 competitive male volleyball players under 19 years of age from the Algerian Amateur League. Participants will be randomly assigned to one of three groups, with 12 players in each group. The first group will conduct a 10-minute reactive training session using BlazePod, an interactive lighting system that requires participants to respond swiftly to visual inputs. The second cohort will engage in a 20-minute session with the identical approach, featuring increased workout repetitions and varied rest intervals. The third group will do 10 minutes of standard volleyball-related workouts without interactive visual indications. All participants will complete one supervised workout session. Blood samples will be collected roughly five minutes before exercise and within two minutes after exercise to assess five substances: epinephrine (adrenaline), norepinephrine (noradrenaline), dopamine, cortisol, and cortisone. These chemicals are involved in the body's responses to physical exertion and stress. Heart rate will also be recorded, and participants will report how physically challenging they found the exercises using a simple grading scale. Investigators will analyse data collected prior to and following physical activity and assess if the variations differ among the three cohorts. The study intends to better understanding of how exercise duration, physical demands, and responsiveness to visual signals may influence acute hormonal responses in young volleyball players. The results could assist researchers and sports experts in comprehending the physical requirements of reactionary exercise and inform subsequent studies on athletic training. The study is not meant to assess if these activities increase long-term sports performance. No results are currently available, and it is not yet known whether one workout strategy will create distinct hormonal reactions from another.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Tipo di studio
Tipo di studio
Iscrizione (Effettivo)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Sétif, Algeria
- Mohamed Lamine Debaghine Setif 2 University.
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Male volleyball players within the U-19 age category.
- Active participation in organized competitive volleyball.
- Sufficient physical capacity to complete the prescribed high-intensity exercise protocols.
- Absence of musculoskeletal injury or medical conditions that could compromise safe participation.
- Willingness to complete the experimental procedures, including pre- and post-exercise venous blood sampling.
Exclusion Criteria:
- Current musculoskeletal injury or persistent pain affecting physical performance.
- Diagnosed cardiovascular, metabolic, endocrine, or neurological disorders that could influence exercise tolerance or biochemical responses.
- Use of medications or substances known to affect sympathetic nervous system activity, catecholamine secretion, or glucocorticoid regulation.
- Inability to complete the assigned exercise protocol or blood sampling procedures.
- Withdrawal of consent at any stage of the investigation.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Scienza basilare
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: High-Intensity Exercise Group
12 individuals are participating in high-intensity physical training as part of supervised sessions. Heart rate and perceived exertion levels will be monitored, and blood samples will be collected before and after the program. |
12 participants will undergo a single high-intensity exercise session under the supervision of specialists. The session will include a warm-up phase, followed by continuous moderate-intensity exercise, and will conclude with a cool-down phase. Exercise intensity will be monitored by measuring heart rate and assessing the perceived level of exertion. Additionally, blood samples will be collected before and after the session to evaluate hormonal responses. |
|
Sperimentale: Moderate-Intensity Exercise Group
12 individuals will participate in moderate-intensity physical training as part of supervised sessions. Heart rate and perceived exertion levels will be monitored, and blood samples will be collected before and after the program. |
12 participants will undergo a single moderate-intensity exercise session under the supervision of specialists. The session will include a warm-up phase, followed by continuous moderate-intensity exercise, and will conclude with a cool-down phase. Exercise intensity will be monitored by measuring heart rate and assessing the perceived level of exertion. Additionally, blood samples will be collected before and after the session to evaluate hormonal responses. |
|
Nessun intervento: Control Group
12 participants will not undergo any physical intervention; instead, they will continue with their usual daily activities. Blood samples will be collected at the same time points established for the exercise groups. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Plasma Epinephrine Level
Lasso di tempo: Before and immediately after the single exercise session
|
Plasma epinephrine concentration measured by blood sample. Change from baseline (before exercise) to immediately after the single exercise session will be compared between the high-intensity, moderate-intensity, and control groups. |
Before and immediately after the single exercise session
|
|
Change in Plasma Norepinephrine Level
Lasso di tempo: Before and immediately after the single exercise session
|
Plasma norepinephrine concentration measured by blood sample. Change from baseline (before exercise) to immediately after the single exercise session will be compared between the high-intensity, moderate-intensity, and control groups. |
Before and immediately after the single exercise session
|
|
Change in Plasma Dopamine Level
Lasso di tempo: Before and immediately after the single exercise session
|
Plasma dopamine concentration measured by blood sample. Change from baseline (before exercise) to immediately after the single exercise session will be compared between the high-intensity, moderate-intensity, and control groups. |
Before and immediately after the single exercise session
|
|
Change in Serum Cortisol Level
Lasso di tempo: Before and immediately after the single exercise session
|
Serum cortisol concentration measured by blood sample. Change from baseline (before exercise) to immediately after the single exercise session will be compared between the high-intensity, moderate-intensity, and control groups. |
Before and immediately after the single exercise session
|
|
Change in Serum Cortisone Level
Lasso di tempo: Before and immediately after the single exercise session
|
Serum cortisone concentration measured by blood sample. Change from baseline (before exercise) to immediately after the single exercise session will be compared between the high-intensity, moderate-intensity, and control groups. |
Before and immediately after the single exercise session
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Peak Heart Rate During Exercise
Lasso di tempo: During the exercise session
|
Peak heart rate (HRpeak) will be measured continuously during each exercise session using a heart rate monitor. HRpeak will then be compared across the three groups: the high-intensity exercise group, the moderate-intensity exercise group, and the control group. |
During the exercise session
|
|
Rating of Perceived Exertion
Lasso di tempo: During and immediately after the single exercise session
|
The Rate of Perceived Exertion (RPE) will be assessed using the Borg scale during and immediately after each exercise session. RPE values will then be compared across the three groups: the high-intensity exercise group, the moderate-intensity exercise group, and the control group. |
During and immediately after the single exercise session
|
Collaboratori e investigatori
Sponsor
Sponsor
Investigatori
Investigatori
- Investigatore principale: YOUSSEF ZEKAILICHE, Ph.D., Mohamed Lamine Debaghine Setif 2 University Laboratory Sciences of Physical Activities, Sports, and Public Health, Algeria.
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Effettivo)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- SETIF2-01-2026
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Individual participant data will not be shared to protect participant confidentiality and privacy, as this is a small single-site. Only aggregated and anonymized results will be reported.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .